Unlike individuals with the “metabolic NAFLD” described in this review, those with PNPLA3-induced NAFLD often remain metabolically healthy, with less insulin resistance, diabetes, and cardiovascular disease (83, 84). This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.